Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Small Plaque Psoriasis”

872 trials

Showing 20 of 872 results

Not applicableStudy completedNCT05344482
What this trial is testing

Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 277
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06926582
What this trial is testing

Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis

Who this might be right for
Psoriasis
Hansoh BioMedical R&D Company 305
Large-scale testing (Phase 3)Study completedNCT01970488
What this trial is testing

Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 350
Testing effectiveness (Phase 2)Study completedNCT01872546
What this trial is testing

Skin Transcriptional Profiles In Psoriatic Patients Under Adalimumab Biotherapy

Who this might be right for
Chronic Plaque Psoriasis
Poitiers University Hospital 15
Not applicableUnknownNCT05036889
What this trial is testing

A 16-week Randomized Evaluation of the Impact of Mind.Px Application on Response to Biologic Treatment in Patients Suffering From Plaque Psoriasis Through Clinical Utility and Health Outcomes.

Who this might be right for
Plaque Psoriasis
Mindera Health 200
Not applicableStudy completedNCT02881346
What this trial is testing

Efficacy and Tolerability of Enstilar® in Daily Practice

Who this might be right for
Plaque Psoriasis
LEO Pharma 410
Large-scale testing (Phase 3)Not Yet RecruitingNCT06943950
What this trial is testing

A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
CSPC Ouyi Pharmaceutical Co., Ltd. 500
Early research (Phase 1)Study completedNCT03669757
What this trial is testing

Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 13
Testing effectiveness (Phase 2)Study completedNCT04999839
What this trial is testing

Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Takeda 259
Early research (Phase 1)Ended earlyNCT01010542
What this trial is testing

Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects

Who this might be right for
Plaque Psoriasis
Pfizer 39
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07150988
What this trial is testing

A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Haisco Pharmaceutical Group Co., Ltd. 150
Large-scale testing (Phase 3)Study completedNCT03897075
What this trial is testing

Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Nail Psoriasis
Sun Pharmaceutical Industries Limited 99
Large-scale testing (Phase 3)Study completedNCT00626002
What this trial is testing

Open Label Continuation Study in Moderate to Severe Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 2,301
Very early researchEnded earlyNCT01317017
What this trial is testing

Cell Responses to IFN-gamma

Who this might be right for
Plaque Psoriasis
Rockefeller University 2
Testing effectiveness (Phase 2)Study completedNCT01001468
What this trial is testing

Study to Assess VB-201 in Patients With Psoriasis

Who this might be right for
Active Plaque Psoriasis
Vascular Biogenics Ltd. operating as VBL Therapeutics 185
Large-scale testing (Phase 3)Study completedNCT06588738
What this trial is testing

A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001

Who this might be right for
Plaque Psoriasis
Alumis Inc 862
Large-scale testing (Phase 3)Ended earlyNCT01708590
What this trial is testing

Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis Subjects

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 661
Testing effectiveness (Phase 2)Study completedNCT05375955
What this trial is testing

Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Who this might be right for
Atopic DermatitisPlaque Psoriasis
Pfizer 263
Post-approval studies (Phase 4)UnknownNCT01558310
What this trial is testing

Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis

Who this might be right for
Scalp PsoriasisPlaque Psoriasis
Paul Steven Yamauchi, MD, PhD 30
Not applicableStudy completedNCT01202565
What this trial is testing

Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 506
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation